Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment

MD Anderson Head and Neck Symptom Working Group, View ORCID ProfileLaia Humbert-Vidan, View ORCID ProfileSerageldin Kamel, View ORCID ProfileAndrew Wentzel, View ORCID ProfileZaphanlene Kaffey, View ORCID ProfileMoamen Abdelaal, View ORCID ProfileKyle B. Spier, View ORCID ProfileNatalie A. West, View ORCID ProfileG. Elisabeta Marai, View ORCID ProfileGuadalupe Canahuate, View ORCID ProfileXinhua Zhang, View ORCID ProfileMelissa M. Chen, View ORCID ProfileKareem A. Wahid, View ORCID ProfileJillian Rigert, View ORCID ProfileSeyedmohammadhossein Hosseinian, View ORCID ProfileAndrew J. Schaefer, View ORCID ProfileKristy K. Brock, View ORCID ProfileMark Chambers, View ORCID ProfileAdegbenga O. Otun, View ORCID ProfileRuth Aponte-Wesson, View ORCID ProfileVinod Patel, View ORCID ProfileAndrew Hope, View ORCID ProfileJack Phan, View ORCID ProfileAdam S. Garden, View ORCID ProfileSteven J. Frank, View ORCID ProfileWilliam H Morrison, View ORCID ProfileMichael T Spiotto, View ORCID ProfileDavid Rosenthal, View ORCID ProfileAnna Lee, View ORCID ProfileRenjie He, View ORCID ProfileMohamed A. Naser, View ORCID ProfileErin Watson, View ORCID ProfileKatherine A. Hutcheson, View ORCID ProfileAbdallah S. R. Mohamed, View ORCID ProfileVlad C. Sandulache, View ORCID ProfileLisanne V. van Dijk, View ORCID ProfileAmy C. Moreno, View ORCID ProfileTeresa Guerrero Urbano, View ORCID ProfileStephen Y. Lai, View ORCID ProfileClifton D. Fuller
doi: https://doi.org/10.1101/2024.08.20.24312311
1The University of Texas MD Anderson Cancer Center
Laia Humbert-Vidan
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laia Humbert-Vidan
Serageldin Kamel
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Serageldin Kamel
Andrew Wentzel
2University of Illinois Chicago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Wentzel
Zaphanlene Kaffey
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zaphanlene Kaffey
Moamen Abdelaal
3Emory School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Moamen Abdelaal
Kyle B. Spier
4Paul L. Foster School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kyle B. Spier
Natalie A. West
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalie A. West
G. Elisabeta Marai
2University of Illinois Chicago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for G. Elisabeta Marai
Guadalupe Canahuate
5University of Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guadalupe Canahuate
Xinhua Zhang
2University of Illinois Chicago
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xinhua Zhang
Melissa M. Chen
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melissa M. Chen
Kareem A. Wahid
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kareem A. Wahid
Jillian Rigert
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jillian Rigert
Seyedmohammadhossein Hosseinian
6North Carolina State University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seyedmohammadhossein Hosseinian
Andrew J. Schaefer
7Rice University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Schaefer
Kristy K. Brock
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kristy K. Brock
Mark Chambers
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Chambers
Adegbenga O. Otun
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adegbenga O. Otun
Ruth Aponte-Wesson
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ruth Aponte-Wesson
Vinod Patel
8Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vinod Patel
Andrew Hope
9University of Toronto / Princess Margaret Cancer Centre, University Health Network
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Hope
Jack Phan
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jack Phan
Adam S. Garden
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Adam S. Garden
Steven J. Frank
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Steven J. Frank
William H Morrison
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William H Morrison
Michael T Spiotto
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael T Spiotto
David Rosenthal
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for David Rosenthal
Anna Lee
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Lee
Renjie He
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Renjie He
Mohamed A. Naser
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mohamed A. Naser
Erin Watson
10Princess Margaret Cancer Centre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erin Watson
Katherine A. Hutcheson
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katherine A. Hutcheson
Abdallah S. R. Mohamed
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Abdallah S. R. Mohamed
Vlad C. Sandulache
11Baylor College of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vlad C. Sandulache
Lisanne V. van Dijk
12University Medical Center Groningen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lisanne V. van Dijk
Amy C. Moreno
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amy C. Moreno
Teresa Guerrero Urbano
8Guy’s and St Thomas’ NHS Foundation Trust
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Teresa Guerrero Urbano
  • For correspondence: cdfuller{at}mdanderson.org
Stephen Y. Lai
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen Y. Lai
  • For correspondence: cdfuller{at}mdanderson.org
Clifton D. Fuller
1The University of Texas MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Clifton D. Fuller
  • For correspondence: cdfuller{at}mdanderson.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has important implications to monitor oral health in head and neck cancer (HNC) long-term survivors.

Methods Demographic, clinical and dosimetric data were retrospectively obtained for a clinical observational cohort of 1129 patients with HNC treated with radiotherapy (RT) at The University of Texas MD Anderson Cancer Center. ORNJ was diagnosed in 198 patients (18%). A multivariable logistic regression analysis with forward stepwise variable selection identified significant predictors for ORNJ. These predictors were then used to train a Weibull Accelerated Failure Time (AFT) model, which was externally validated using an independent cohort of 265 patients (92 ORNJ cases and 173 controls) treated at Guy’s and St. Thomas’ Hospitals.

Findings Our model identified that each unit increase in D25% is significantly associated with a 12% shorter time to ORNJ (Adjusted Time Ratio [ATR] 0·88, p<0·005); pre-RT dental extractions was associated to a 27% faster (ATR 0·73, p=0·13) onset of ORNJ; male patients experienced a 38% shorter time to ORNJ (ATR 0·62, p = 0·11). The model demonstrated strong internal calibration (integrated Brier score of 0·133, D-calibration p-value 0.998) and optimal discrimination at 72 months (Harrell’s C-index of 0·72). The model also showed good generalization to the independent cohort, despite a slight drop in performance.

Interpretation This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose not only on the probability of a late effect (ORNJ), but the conditional risk during survivorship.

Funding This work was supported by various funding sources including NIH, NIDCR, NCI, NAPT, NASA, BCM, Affirmed Pharma, CRUK, KWF Dutch Cancer Society, NWO ZonMw, and the Apache Corporation.

Competing Interest Statement

S.J.F. is a consultant at Boston Scientific and founder and member of the Scientific Advisory Committee (with patient/royalties) at C4 Imaging. J.P. COI disclosures: Nanobiotix; TAE Life Sciences Clinical Advisory Board 2020-2023. C.D.F. receives unrelated patent royalties from Kallisio, Inc, and unrelated travel and honoraria from Elekta AB, Philips Medical Systems, Siemens Healthineers/Varian, and Corewell Health. C.D.F. holds patents through the University of Texas (US PTO 11730561) licensed to Kallisio, Inc. V.C.S. is a consultant for, and equity holder in Femtovox Inc and a consultant for PDS Biotechnology. K.A.W. serves as an Editorial Board Member for Physics and Imaging in Radiation Oncology. C.D.F. has served on guidelines/scientific committee for Osteoradionecrosis for the American Society of Clinical Oncology.

Funding Statement

The authors would like to acknowledge the support from various funding sources that made this work possible. C.D.F. and S.Y.L. received related funding support from the NIH/NIDCR (U01DE032168/ R01DE025248). C.D.F. also receives infrastructure and salary support through the NIH/NCI MD Anderson Cancer Center Core Support Grant (CCSG) Image-Driven Biologically-informed Therapy (IDBT) program (P30CA016672-47). S.Y.L. is supported through the CCSG Head and Neck Program (P30CA016672-48). T.G.U. is supported by the Radiation Research Unit at the Cancer Research UK City of London Centre Award [C7893/A28990]. A.C.M. received funding from the NIH/NIDCR via grants K12CA088084, R21DE031082, and K01DE030524. L.V.V. received funding and salary support from KWF Dutch Cancer Society through a Young Investigator Grant (KWF-13529) and from NWO ZonMw through the VENI grant (NWO-09150162010173). K.K.B. acknowledges support from the Image Guided Cancer Therapy Research Program at The University of Texas MD Anderson Cancer Center, which was partially funded by the National Institutes of Health/NCI under award number P30CA016672 and through a generous gift from the Apache Corporation. M.A.N. received funding from the National Institutes of Health/National Institute of Dental and Craniofacial Research (NIH/NIDCR) through grant 1R03DE033550-01. J.R. received salary support from the NIDCR Diversity Supplement Grant 3R01DE028290-02S1. K.A.W. was supported by the Image-Guided Cancer Therapy T32 Training Program Fellowship from T32CA261856. A.J.S. received funding from the NIH/NCI through grant R01CA257814-01. N.A.W. acknowledges funding support from 5R01DE028290-05. G.E.M. acknowledges funding support from NIH UG3 TR004501, NSF CNS-2320261, the University Scholar Award from the University of Illinois System, and NIH/NCI R01CA258827. A.S.R.M. received funding from NIDCR (U01DE032168, 1R01DE028290-01A1) and NCI (R01 CA258827). S.J.F. received funding from Hitachi, NIH/NCI, the National Association of Proton Therapy, Affirmed Pharma and NASA/Baylor College of Medicine and honoraria from IBA.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

After institutional review board approval (RCR030800), data from a philanthropically funded observational cohort at The University of Texas MD Anderson Cancer Center (Stiefel Oropharynx Cancer Cohort, PA14-0947) were extracted for retrospective acquisition. An external cohort was obtained retrospectively from the HNC clinical database maintained at GSTT under the Northwest - Haydock Research Ethics Committee of the NHS Health Research Authority (REC reference 18/NW/0297, IRAS project ID: 231443)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ↵* co-first authors

Data availability statement

The MDACC deidentified dataset is available in Figshare (10.6084/m9.figshare.26240435). The GSTT dataset was analyzed onsite using a federated method and, due to GDPR restrictions, cannot be made public. Open access/FAIR reporting of scripts and instructions for the model are available in GitHub (https://github.com/LaiaHV-MDACC/ORN-time-to-event-prediction-modelling).

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 20, 2024.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institution…
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment
MD Anderson Head and Neck Symptom Working Group, Laia Humbert-Vidan, Serageldin Kamel, Andrew Wentzel, Zaphanlene Kaffey, Moamen Abdelaal, Kyle B. Spier, Natalie A. West, G. Elisabeta Marai, Guadalupe Canahuate, Xinhua Zhang, Melissa M. Chen, Kareem A. Wahid, Jillian Rigert, Seyedmohammadhossein Hosseinian, Andrew J. Schaefer, Kristy K. Brock, Mark Chambers, Adegbenga O. Otun, Ruth Aponte-Wesson, Vinod Patel, Andrew Hope, Jack Phan, Adam S. Garden, Steven J. Frank, William H Morrison, Michael T Spiotto, David Rosenthal, Anna Lee, Renjie He, Mohamed A. Naser, Erin Watson, Katherine A. Hutcheson, Abdallah S. R. Mohamed, Vlad C. Sandulache, Lisanne V. van Dijk, Amy C. Moreno, Teresa Guerrero Urbano, Stephen Y. Lai, Clifton D. Fuller
medRxiv 2024.08.20.24312311; doi: https://doi.org/10.1101/2024.08.20.24312311
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment
MD Anderson Head and Neck Symptom Working Group, Laia Humbert-Vidan, Serageldin Kamel, Andrew Wentzel, Zaphanlene Kaffey, Moamen Abdelaal, Kyle B. Spier, Natalie A. West, G. Elisabeta Marai, Guadalupe Canahuate, Xinhua Zhang, Melissa M. Chen, Kareem A. Wahid, Jillian Rigert, Seyedmohammadhossein Hosseinian, Andrew J. Schaefer, Kristy K. Brock, Mark Chambers, Adegbenga O. Otun, Ruth Aponte-Wesson, Vinod Patel, Andrew Hope, Jack Phan, Adam S. Garden, Steven J. Frank, William H Morrison, Michael T Spiotto, David Rosenthal, Anna Lee, Renjie He, Mohamed A. Naser, Erin Watson, Katherine A. Hutcheson, Abdallah S. R. Mohamed, Vlad C. Sandulache, Lisanne V. van Dijk, Amy C. Moreno, Teresa Guerrero Urbano, Stephen Y. Lai, Clifton D. Fuller
medRxiv 2024.08.20.24312311; doi: https://doi.org/10.1101/2024.08.20.24312311

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)